As the New Year rises, a hopeful horizon brightens for Cure JM. It is with great thanks to our Cure JM community for your extraordinary commitment to funding new research as we move into 2024. Celebrate the achievements with us and review our community’s impact and our goals for the new year.
Jim Minow, Executive Director, updates on recent research breakthroughs, new treatment options, and plans to expand Cure JM’s Clinical Care Network.
Andrew Heaton, Chief Scientific Officer, updates families with the latest information on new treatments on the horizon, including deucravacitinib and vamorolone.
Shannon Malloy, Director of Family and Community Engagement, discusses the latest developments in physician education programs, family education and support programs, and our plans for family connections in the coming year.
Click the image above to watch the informative presentation.
